Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway.
Saved in:
| Title: | Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway. |
|---|---|
| Authors: | Gedde-Dahl A; Faculty of Health Sciences, Oslo Metropolitan University, P.O. Box 4 St. Olavs plass, N-0130, Oslo, Norway. ane.gedde-dahl@oslomet.no., Spigset O; Department of Clinical Pharmacology, St. Olav's University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Molden E; Department of Pharmacy, University of Oslo, Oslo, Norway.; Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway. |
| Source: | European journal of clinical pharmacology [Eur J Clin Pharmacol] 2022 Oct; Vol. 78 (10), pp. 1623-1632. Date of Electronic Publication: 2022 Jul 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
